Moreover, evidence indicate that bone marrow derived cells expressing TLR9 are responsible for macrophage and neutrophil recruitment in a NASH model and that Tlr9 deletion allows a reduction of hepatic inflammation (142). This evidence concerns the gene TLR9 and metabolic dysfunction-associated steatohepatitis.